Levothyroxine sodium
- Product NDC
- 0480-8690
- 11-digit product format
- 004808690
- Labeler code
- 0480
- Product ID
- 0480-8690_8f65417f-488f-4e4a-894c-56f99ed57d25
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals, Inc.
- Application
- ANDA207588
- Marketing category
- ANDA
- Marketing start
- 2022-09-21
- Marketing end
- 2026-11-30
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 75 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 9J765S329G | LEVOTHYROXINE SODIUM | 6106-07-6 | LEVOTHYROXINE SODIUM |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0480-8690-10 | 00480869010 | 1000 TABLET in 1 BOTTLE (0480-8690-10) | 1000 tablet | 2022-09-21 | 2026-11-30 | No | No | Historical |
| 0480-8690-98 | 00480869098 | 90 TABLET in 1 BOTTLE (0480-8690-98) | 90 tablet | 2022-09-21 | 2026-11-30 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Levothyroxine sodium | Teva Pharmaceuticals, Inc. | 2024-06-25 | HUMAN PRESCRIPTION DRUG LABEL | 6 |
| Levothyroxine sodium | Teva Pharmaceuticals, Inc. | 2024-06-01 | HUMAN PRESCRIPTION DRUG LABEL | 8 |